Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Fatigue Alleviation Through Neuromodulating Therapy in Multiple Sclerosis — Stella

Home/Multiple Sclerosis, Relapsing-Remitting/Fatigue Alleviation Through Neuromodulating Therapy in Multiple Sclerosis

View on ClinicalTrials.gov

Recruiting

Back to Multiple Sclerosis, Relapsing-Remitting trials

Fatigue Alleviation Through Neuromodulating Therapy in Multiple Sclerosis

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Denmark

Danish Research Centre for Magnetic Resonance, Hvidovre, Capital Region

Key details

Sponsor

Danish Research Centre for Magnetic Resonance

Collaborators

Danish Multiple Sclerosis Center, Scleroseforeningen

Enrollment target

~60 participants

Started

August 2024

Primary completion

September 2026

Age range

18 Years – 65 Years

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.